GoyesD, NjeiB, LimJK. Incidence, cost, and mortality of AKI and HRS in patients with cirrhosis. JAMA Netw Open2025;8(5):e2511822; doi: 10.1001/jamanetworkopen.2025.11822
2.
NadimMK, KellumJA, ForniL, et al.Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol2024;81(1):163–183; doi: 10.1016/j.jhep.2024.03.031
3.
KaewputW, ThongprayoonC, DumancasCY, et al.In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample. World J Gastroenterol2021;27(45):7831–7843; doi: 10.3748/wjg.v27.i45.7831
4.
PoseE, PianoS, JuanolaA, et al.Hepatorenal syndrome in cirrhosis. Gastroenterology2024;166(4):588–604.e1; doi: 10.1053/j.gastro.2023.11.306
5.
BigginsSW, AngeliP, Garcia‐TsaoG, et al.Diagnosis, evaluation, and management of ascites and hepatorenal syndrome. Hepatology2021;74(2); doi: 10.1002/hep.31884
6.
El-Desoki MahmoudEI, AbdelazizDH, Abd-ElsalamS, et al.Norepinephrine is more effective than midodrine/octreotide in patients with hepatorenal syndrome-acute kidney injury: A randomized controlled trial. Front Pharmacol2021;12:675948; doi: 10.3389/fphar.2021.675948
7.
GonzalezSA, ChirikovVV, WangWJ, et al.Terlipressin vs midodrine plus octreotide for hepatorenal syndrome-acute kidney injury: A propensity score-matched comparison. Clin Transl Gastroenterol2023;14(12):e00627; doi: 10.14309/ctg.0000000000000627
8.
WongF, PappasSC, CurryMP, CONFIRM Study Investigators. et al.; Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med2021;384(9):818–828; doi: 10.1056/NEJMoa2008290
9.
ZhangZ, MaddukuriG, JaipaulN, et al.Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin. J Crit Care2015;30(5):969–974; doi: 10.1016/j.jcrc.2015.05.006
10.
KimbellB, BoydK, KendallM, et al.Managing uncertainty in advanced liver disease: A qualitative, multiperspective, serial interview study. BMJ Open2015;5(11):e009241; doi: 10.1136/bmjopen-2015-009241
